(Reuters) - U.S. health regulators approved Indian drugmaker Dr Reddy's Laboratories' application to market generic version of AstraZeneca Plc's blood-pressure medicine Toprol-XL.
Shares of the company were up 1.51 percent at 1,671 rupees as of 0712 GMT.
(Reporting by Kaustubh Kulkarni in Mumbai; Editing by Anand Basu)
Source: http://news.yahoo.com/indias-dr-reddys-u-nod-blood-pressure-tablets-071843695--finance.html
nfl hall of fame 2012 ufc diaz vs condit josephine baker super bowl start time target jason wu gi joe jason wu for target collection
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.